Hangzhou Bioer Technology Co., Ltd.
PrivateLast Round
IPO
Dec 15, 2021
Total Funding Raised
$68.8M
Company Overview
Hangzhou Bioer Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in May 2021.
Hangzhou Bioer Technology Co., Ltd. is a biotechnology company that specializes in the research, development, manufacturing, and sales of molecular detection products, including instruments, reagents, and consumables for life science and medical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Bioer Technology Co., Ltd. Comparables
Compare Hangzhou Bioer Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jiangsu Bioperfectus Technologies Co Ltd | 90% | |
| Daan Gene Co., Ltd. | 86% | |
| Shanghai Kehua Bio-Engineering Co Ltd | 84% |
For institutional investors. Book with your work email.
Hangzhou Bioer Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 15, 2021 | ||||
| Series B | May 8, 2021 | ||||
| Series A | Jul 22, 2020 |
For institutional investors. Book with your work email.
Hangzhou Bioer Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGI Co-Win | Series A |
| Shanghai Free Trade Zone Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2021
$60.2M round with Zhejiang Provincial Department of Finance.
- Jul 22, 2020
$9M round with participation from BGI Co-Win and others.
For institutional investors. Book with your work email.
Hangzhou Bioer Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou Bioer Technology Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Bioer Technology Co., Ltd. a public or private company?
Hangzhou Bioer Technology Co., Ltd. is a private company.
What is the current stock price of Hangzhou Bioer Technology Co., Ltd.?
Hangzhou Bioer Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Bioer Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou Bioer Technology Co., Ltd. worth (valuation)?
Valuation information for Hangzhou Bioer Technology Co., Ltd. is not publicly available.
Can I buy Hangzhou Bioer Technology Co., Ltd. stock?
Hangzhou Bioer Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou Bioer Technology Co., Ltd.'s last funding round?
Hangzhou Bioer Technology Co., Ltd.'s most recent funding round was IPO on December 15, 2021.
Who are the main investors in Hangzhou Bioer Technology Co., Ltd.?
Key investors in Hangzhou Bioer Technology Co., Ltd. include BGI Co-Win, Shanghai Free Trade Zone Fund.
Will Hangzhou Bioer Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Bioer Technology Co., Ltd..
How can I track Hangzhou Bioer Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou Bioer Technology Co., Ltd.'s shares on secondary markets.